Microwave tumors ablation: principles, clinical applications and review of preliminary experiences.

Department of Radiology, University of Insubria, Varese, Italy.
International Journal of Surgery (London, England) (Impact Factor: 1.44). 01/2009; 6 Suppl 1:S65-9. DOI: 10.1016/j.ijsu.2008.12.028
Source: PubMed

ABSTRACT Local ablative techniques have been developed to enable local control of unresectable tumors. Ablation has been performed with several modalities including ethanol ablation, laser ablation, cryoablation, and radiofrequency ablation. Microwave technology is a new thermal ablation technique for different types of tumors, providing all the benefits of radiofrequency and substantial advantages. Microwave ablation has been applied to liver, lung, kidney and more rarely to bone, pancreas and adrenal glands. Preliminary works show that microwave ablation may be a viable alternative to other ablation techniques in selected patients. However further studies are necessary to confirm short- and long-term effectiveness of the methods and to compare it with other ablative techniques, especially RF.

1 Bookmark
  • [Show abstract] [Hide abstract]
    ABSTRACT: Transdermal drug delivery is hindered by the barrier property of stratum corneum. It limits the route to transport of drugs with a log octanol-water partition coefficient of 1 to 3, molecular weight of less than 500 Da and melting point of less than 200°C. Active methods such as iontophoresis, electroporation, sonophoresis, magnetophoresis and laser techniques have been investigated for the past decades on their ability, mechanisms and limitations in modifying the skin microenvironment to promote drug diffusion and partition. Microwave, an electromagnetic wave characterized by frequencies range between 300 MHz and 300 GHz, has recently been reported as the potential skin permeation enhancer. Microwave has received a widespread application in food, engineering and medical sectors. Its potential use to facilitate transdermal drug transport is still in its infancy stage of evaluation. This review provides an overview and update on active methods utilizing electrical, magnetic, photomechanical and cavitational waves to overcome skin barrier for transdermal drug administration with insights to mechanisms and future perspectives of the latest microwave technique described.
    Journal of Controlled Release 05/2014; · 7.63 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Image-guided thermal ablation is used to treat primary and secondary liver cancers. Evaluating completeness of ablation is difficult with standard intraoperative B-mode ultrasound. This study evaluates the ability of B-mode ultrasound (US) and tissue elastography to adequately measure the extent of ablation compared to pathologic assessment. An in vivo porcine model was used to compare B-mode ultrasonography and elastography to pathologic assessment of the microwave ablation zone area. In parallel, intraoperative ablations in patients were used to assess the ability of B-mode US and elastographic measures of tissue strain immediately after ablation to predict ablation size, compared to postprocedural computed tomography (CT). In the animal model, ablation zones appeared to decrease in size when monitored with ultrasound over a 10-minute span with both B-mode US and elastography. Both techniques estimated smaller zones than gross pathology, however, the differences did not reach statistical significance. Biopsies from the edges of the ablation zone, as assessed by US, contained viable tissue in 75% of the cases. In the human model, B-mode US and elastography estimated similar ablation sizes; however, they underestimate the final size of the ablation defect as measured on postprocedure CT scan (median area [interquartile range]: CT, 7.3 cm(2) [5.2-9.5] vs. US 3.6 cm(2) [1.7-6.3] and elastography 4.1 cm(2) [1.4-5.1]; P = .005). Ultrasound and elastography provide an accurate gross estimation of ablation zone size but are unable to predict the degree of cellular injury and significantly underestimate the ultimate size of the ablation.
    Academic radiology 01/2014; 21(1):72-78. · 2.09 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: We compared imaging and pathological changes between argon-helium cryosurgical (AH) and microwave (MW) ablation in a porcine liver model. Immediately after ablation, computed tomography (CT) imaging showed that the area affected by MW ablation was considerably greater than that affected by AH ablation; moreover, the surface area of necrotic tissue was considerably greater in the AH group, whereas the depth of the necrotic area was similar. Seven days after ablation, the affected area had not changed much in the AH group, but it had significantly increased in the MW group; similarly, the surface and depth of the necrotic areas had not changed much in the AH group, but they had increased significantly in the MW group. The pathological findings showed similar definitive areas for both groups at both time points. The findings indicated that long time after both therapies, complete tissue necrosis can be achieved, but the extent and depth of necrosis differ: necrosis foci after AH ablation could be predicted by ice ball under CT image, and necrosis foci after MW ablation will increase obviously. MW ablation might therefore be suitable for tumors with a larger volume and simple anatomical structures, and AH ablation might be suitable for tumors with complex anatomical structures or those located near important organs. These two methods could therefore be used in combination in clinical settings, but details of the procedure need to be studied.
    Cryobiology 01/2014; · 2.14 Impact Factor